112 related articles for article (PubMed ID: 38678014)
21. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.
Risom T; Glass DR; Averbukh I; Liu CC; Baranski A; Kagel A; McCaffrey EF; Greenwald NF; Rivero-Gutiérrez B; Strand SH; Varma S; Kong A; Keren L; Srivastava S; Zhu C; Khair Z; Veis DJ; Deschryver K; Vennam S; Maley C; Hwang ES; Marks JR; Bendall SC; Colditz GA; West RB; Angelo M
Cell; 2022 Jan; 185(2):299-310.e18. PubMed ID: 35063072
[TBL] [Abstract][Full Text] [Related]
22. A multi-functional microfluidic device compatible with widefield and light sheet microscopy.
Moore RP; O'Shaughnessy EC; Shi Y; Nogueira AT; Heath KM; Hahn KM; Legant WR
Lab Chip; 2021 Dec; 22(1):136-147. PubMed ID: 34859808
[TBL] [Abstract][Full Text] [Related]
23. Dual-view light-sheet imaging through a tilted glass interface using a deformable mirror.
Vladimirov N; Preusser F; Wisniewski J; Yaniv Z; Desai RA; Woehler A; Preibisch S
Biomed Opt Express; 2021 Apr; 12(4):2186-2203. PubMed ID: 33996223
[TBL] [Abstract][Full Text] [Related]
24. A method for systematically ranking therapeutic drug candidates using multiple uncertain screening criteria.
Peng X; Gibbs E; Silverman JM; Cashman NR; Plotkin SS
Stat Methods Med Res; 2021 Jun; 30(6):1502-1522. PubMed ID: 33847541
[TBL] [Abstract][Full Text] [Related]
25. Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs.
Gerdes H; Casado P; Dokal A; Hijazi M; Akhtar N; Osuntola R; Rajeeve V; Fitzgibbon J; Travers J; Britton D; Khorsandi S; Cutillas PR
Nat Commun; 2021 Mar; 12(1):1850. PubMed ID: 33767176
[TBL] [Abstract][Full Text] [Related]
26. Iterative sure independent ranking and screening for drug response prediction.
An B; Zhang Q; Fang Y; Chen M; Qin Y
BMC Med Inform Decis Mak; 2020 Sep; 20(Suppl 8):224. PubMed ID: 32962705
[TBL] [Abstract][Full Text] [Related]
27. Snail promotes the generation of vascular endothelium by breast cancer cells.
Chang Z; Zhang Y; Liu J; Zheng Y; Li H; Kong Y; Li P; Peng H; Shi Y; Cao B; Ran F; Chen Y; Song Y; Ye Q; Ding L
Cell Death Dis; 2020 Jun; 11(6):457. PubMed ID: 32541667
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy.
Henke E; Nandigama R; Ergün S
Front Mol Biosci; 2019; 6():160. PubMed ID: 32118030
[TBL] [Abstract][Full Text] [Related]
29. Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model.
Ishikawa M; Yamamoto T
Exp Dermatol; 2021 Jan; 30(1):179-184. PubMed ID: 32096250
[TBL] [Abstract][Full Text] [Related]
30. Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells.
Wörsdörfer P; Dalda N; Kern A; Krüger S; Wagner N; Kwok CK; Henke E; Ergün S
Sci Rep; 2019 Oct; 9(1):15663. PubMed ID: 31666641
[TBL] [Abstract][Full Text] [Related]
31. Determining cell type abundance and expression from bulk tissues with digital cytometry.
Newman AM; Steen CB; Liu CL; Gentles AJ; Chaudhuri AA; Scherer F; Khodadoust MS; Esfahani MS; Luca BA; Steiner D; Diehn M; Alizadeh AA
Nat Biotechnol; 2019 Jul; 37(7):773-782. PubMed ID: 31061481
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy in colorectal cancer: rationale, challenges and potential.
Ganesh K; Stadler ZK; Cercek A; Mendelsohn RB; Shia J; Segal NH; Diaz LA
Nat Rev Gastroenterol Hepatol; 2019 Jun; 16(6):361-375. PubMed ID: 30886395
[TBL] [Abstract][Full Text] [Related]
33. Large-scale medical image annotation with crowd-powered algorithms.
Heim E; Roß T; Seitel A; März K; Stieltjes B; Eisenmann M; Lebert J; Metzger J; Sommer G; Sauter AW; Schwartz FR; Termer A; Wagner F; Kenngott HG; Maier-Hein L
J Med Imaging (Bellingham); 2018 Jul; 5(3):034002. PubMed ID: 30840724
[TBL] [Abstract][Full Text] [Related]
34. Organ-on-a-Chip for Cancer and Immune Organs Modeling.
Sun W; Luo Z; Lee J; Kim HJ; Lee K; Tebon P; Feng Y; Dokmeci MR; Sengupta S; Khademhosseini A
Adv Healthc Mater; 2019 Feb; 8(4):e1801363. PubMed ID: 30605261
[TBL] [Abstract][Full Text] [Related]
35. Zoledronic acid exacerbates inflammation through M1 macrophage polarization.
Kaneko J; Okinaga T; Hikiji H; Ariyoshi W; Yoshiga D; Habu M; Tominaga K; Nishihara T
Inflamm Regen; 2018; 38():16. PubMed ID: 29977413
[TBL] [Abstract][Full Text] [Related]
36. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
37. LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy.
Rossow L; Veitl S; Vorlová S; Wax JK; Kuhn AE; Maltzahn V; Upcin B; Karl F; Hoffmann H; Gätzner S; Kallius M; Nandigama R; Scheld D; Irmak S; Herterich S; Zernecke A; Ergün S; Henke E
Oncogene; 2018 Sep; 37(36):4921-4940. PubMed ID: 29780168
[TBL] [Abstract][Full Text] [Related]
38. Current state of immunotherapy for glioblastoma.
Lim M; Xia Y; Bettegowda C; Weller M
Nat Rev Clin Oncol; 2018 Jul; 15(7):422-442. PubMed ID: 29643471
[TBL] [Abstract][Full Text] [Related]
39. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.
Schaaf MB; Garg AD; Agostinis P
Cell Death Dis; 2018 Jan; 9(2):115. PubMed ID: 29371595
[TBL] [Abstract][Full Text] [Related]
40. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
